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Intrarectal infection by HIV, the causative agent 
of AIDS, is an important mode of HIV trans-
mission currently accounting for over 400,000 
cases in the United States. Presently, rhesus ma-
caques (1) inoculated intrarectally with simian 
immunodefi ciency virus (SIV) or SIV/HIV chi-
meric viruses (SHIV) are the principal surro-
gate animal model to study intrarectal HIV 
infection. There are no small animal models for 
this mode of HIV transmission or to study in-
fection in the gastrointestinal (GI) tract, which 
in the early stages of HIV infection of humans, 
is a major site of virus replication. Subsequent 
depletion of CD4+ T cells in gut-associated 
lymphoid tissue (GALT) is a defi ning event in 
the course and outcome of disease (2, 3). With 
the aim of elucidating the molecular determi-
nants of HIV transmission via the rectum and 
to establish a small animal model in which the 
effi  cacy of early drug prophylaxis, microbicides, 
and vaccines could be tested, we determined 
the susceptibility of bone marrow/liver/thymus 
(BLT) humanized mice (4) to intrarectal infec-
tion with HIV-1. In BLT mice, the bone mar-
row is reconstituted with human hematopoietic 
stem cells producing all human lymphoid lin-
eages resulting in systemic repopula tion. In ad-
dition, bone marrow–derived T cell progenitors 
are produced that repopulate an  implanted hu-
man organoid consisting of a piece of autolo-
gous fetal liver and thymus resulting in human 
MHC-restricted functional T cells (4).
In this report, we demonstrate the in vivo 
repopulation of the mouse GALT with human 
hematopoietic cells derived from transplanted 
human stem cells. Based on this ob servation, 
we also provide the fi rst demonstration of the 
exquisite susceptibility of BLT mice to intra-
rectal infection by cell-free HIV-1 that results 
in systemic infection including plasma vire-
mia, systemic CD4+ T cell depletion, and the 
production of HIV- specifi c  human antibodies. 
Intrarectal infection of BLT mice represents a 
signifi cant advance that will facilitate the imple-
mentation of  microbicides and prophylactics to 
prevent HIV transmission.
RESULTS AND D I S C U S S I O N 
Reconstitution of the BLT GALT 
with human lymphocytes
NOD/SCID mice are devoid of endogenous B 
and T cells, and therefore, the mouse component 
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Figure 1. Reconstitution of the GI tract of humanized BLT mice. 
(A) Immunohistochemical analysis of the small intestine of a BLT mouse 
for the presence of human hematopoietic cells. Histological analysis was 
performed on fi xed/paraffi n-embedded tissue sections for human CD45 
(pan lymphocyte marker), CD4 (T cells, monocytes, and macrophages), 
CD68 (monocytes and macrophages), and fascin (dendritic cells) as previ-
ously described (4). Panels are small intestine lamina propria (effector 
site), and inserts are follicular lymphoid aggregates (inductive site). Bars, 
50 μm. Sections stained with isotype-matched control antibodies did not 
show staining in these tissues (not depicted). In addition, staining for 
human CD11c and HLA-DR of a BLT mouse together with staining of a 
nonhumanized mouse with the same primary and secondary antibodies 
as an additional control are shown in Fig. S1. (B) Reconstitution of the 
GI tract from humanized mice. The entire GI tract was harvested 24 wk 
after transplant and separated into mesenteric LNs and large and small 
intestine. IELs and LPLs were isolated from both large and small intestines. 
Human hematopoietic cells were identifi ed with anti–human CD45 anti-
bodies and characterized for expression of lineage and differentiation 
specifi c markers as indicated in the different panels. Human T cells in this 
analysis were sequentially gated as CD45+®CD3+ or CD19+. CD45+CD3+ 
cells were analyzed for CD4+ or CD8+ expression (indicated with longer 
arrow between fi rst and second panels). CD4+ or CD8+ cells were further 
analyzed for CD27 and CD45RA expression (indicated by the shorter 
 arrow between the second and third row of panels for CD4+ cells and a 
JEM VOL. 204, April 16, 2007 707
BRIEF DEFINITIVE REPORT
to mucosal immunity is limited to myeloid cells. To deter-
mine if human lymphoid cells encounter adequate signals to 
migrate into and repopulate the mouse GI tract, we fi rst har-
vested the small intestine of humanized BLT mice (n = 7) 
and determined the presence of human hematopoieitic cells 
24 wk after transplant. Histological analysis indicated an 
abundant accumulation of CD45+ hematopoietic cells that 
included human CD4+ cells, monocyte/macrophages, and 
DCs (Fig. 1 A and Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20062411/DC1). We then char acterized 
the human he matopoietic cells in diff erent parts of the GI 
tract from humanized BLT mice by isolating lamina propria 
lymphocytes (LPLs) and intraepithelial lymphocytes (IELs) 
from large and small intestine. In all cases, the gating strategy 
for fl ow cytometric analysis fi rst identifi ed human lymphoid 
cells based on their expression of the human leukocyte com-
mon marker CD45 and then by the appropriate lineage 
marker (i.e., CD3 or CD19) followed by the specifi c subset 
(i.e., CD4 and/or CD8). All portions of the mouse GALT 
were reconstituted with human hematopoietic cells, albeit 
at diff erent levels (Fig. 1 B). Human CD19+ B and CD3+ 
T cells were identifi ed in all fractions with single positive 
CD4 and CD8 human T cells representing the majority of 
human lymphoid cells in all portions of the reconstituted 
GALT. Substantial numbers of intra epithelial (IE) and lamina 
propria (LP) CD4+CD8+ double positive human T cells 
were found in the small intestine (Fig. 1 B). The CD8 mole-
cule expressed on human double positive T cells present in 
the LP was predominantly the CD8α chain (Fig. 1 C). In 
contrast, the CD8 single positive cells in the LP expressed 
both the CD8α and CD8β chains (Fig. 1 C). These observa-
tions are fully consistent with what has been described for 
human gut (5, 6). Also consistent with what has been found 
in human gut, DCs represent a small proportion of the 
human lymphoid cells present, and lineage negative HLA-
DRbright CD11c+ DC were most prominent in the small 
intestine IEL and LPL fractions (Fig. S1) (7). Phenotypic 
characterization of the T cells present in the diff erent GALT 
fractions indicated that the majority of both CD4+ and 
CD8+ human T cells were CD27+CD45RA− memory cells. 
Because the mesenteric LNs are the secondary lymphatic 
tissues that drain the GI tract and play a major role in virus 
dissemination after intrarectal HIV infection, we  determined 
that these important lymphoid tissues were also reconstituted 
with human T and B cells. In contrast to LPL and IEL, mesenteric 
LN contained a clear population of naive (CD45RA+CD27+) 
T cells that were absent from the GALT.
Differential expression of CCR5 and CXCR4 in the BLT GALT
Coreceptor expression in human CD4+ cells is the major 
 determinant of HIV tropism in vivo (8). Analysis of both 
CD4+ and CD8+ T cells present in the GALT of BLT mice 
indicated diff erential expression of CXCR4 and CCR5. The 
proportion of cells expressing CXCR4 and their respective 
expression levels were generally low in all fractions of the 
GALT except the mesenteric LN (Fig. 1 D for one representa-
tive BLT mouse and Fig. 1 E for the average [±SEM] for 
seven BLT mice). In contrast, the levels of expression and the 
proportion of cells expressing CCR5 were signifi cantly higher 
in all fractions of the GALT (Fig. 1, D and E). Analysis of 
CCR5 expression on T cells in the gut with those from other 
lymphoid and nonlymphoid tissues demonstrated that the 
highest proportion of CD4+ CCR5+ cells were found in the 
GALT (Fig. 1 E). These results are consistent with what has 
been previously observed in human and macaque GALT 
(9–11) and extend our understanding to other organs like the 
liver and spleen. Collectively, these data establish the reconstitu-
tion of the GALT of humanized BLT mice with all of the hu-
man  hematopoietic cells relevant to mucosal HIV transmission. 
Furthermore, phenotypic analysis of GI tract and mesenteric 
LN demonstrates that they are reconstituted in a manner that 
closely resembles that of normal human and  macaque tissues.
Intrarectal infection of BLT mice with HIV-1
Because the anus, rectum, and colon are the most likely ana-
tomical sites of initial infection after intrarectal exposure, we 
determined that these regions of the BLT mouse intestinal 
tract were repopulated with human CD4+ T cells (Fig. 2 A). 
CD4+ cells were found in abundant clusters within the fol-
licular aggregates and throughout the lamina propria of both 
colon and rectum. Because we found that humanized BLT 
mice had human CD4+ T cells throughout their GALT, we 
were encouraged to determine the susceptibility of the BLT 
mice to infection by HIV-1 administered intrarectally. Both 
nonhumanized control (n = 4) and humanized BLT mice 
(repopulated with human cells, n = 7) were inoculated intra-
rectally with a single dose of cell-free HIV-1 (LAI CXCR4 
strain, 200 ng p24 in PBS) and subsequently monitored for 
evidence of infection by assays for viral load and HIV antigen-
emia in the plasma. None of the HIV inoculated nonhuman-
ized control mice showed any evidence of infection either 
in the plasma or in the tissues upon necropsy (not depicted). 
Similarly, none of the uninfected humanized BLT control mice 
showed evidence of infection (n = 4). In contrast, viral RNA and 
HIV antigenemia (capsid p24) were evident in the plasma of six 
large arrow between the second and fourth row of panels for CD8+ cells). 
In all cases individual gates were set using isotype-matched controls (not 
depicted). (C) Small intestine IEL and LPL CD8+ and CD4+CD8+ cells were 
further analyzed for their differential expression of CD8α and CD8β 
chains using the same gating strategy as for B. D shows a comparison of 
the levels of HIV coreceptor expression in human CD4+ and CD8+ T cells 
isolated from the large and small intestine and the mesenteric LNs of BLT 
mice. CD45+CD3+CD4+ or CD45+CD3+CD8+ cells from a representative 
mouse were analyzed for expression of CXCR4 or CCR5. (E) Distribution of 
CCR5 and CXCR4 coreceptor expression in human T cell subsets in gut, 
lymphoid, and nonlymphoid tissues of humanized BLT mice. Shown are 
averages of the indicated replicates with their respective error bars 
(±SEM). Gating was performed in the same manner as indicated in D. 
DP, double positive.
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Figure 2. Intrarectal HIV infection of humanized BLT mice. 
(A) Immunohistochemical analysis of the colon and rectum of humanized 
BLT mice for the presence of human lymphocytes expressing CD4. Histo-
logical analysis was performed on fi xed/paraffi n-embedded tissue sections 
as previously described (4). Shown are two magnifi cations of each tissue 
(top and bottom) where bars indicate 25 μm and 12.5 μm, respectively. 
Sections stained with isotype-matched control antibodies did not 
show staining in these tissues and no cross-reactivity was observed with 
NOD/SCID mice tissue stained with anti–human CD4-specifi c antibodies 
(not depicted and Fig. S1). (B) Peripheral blood from intrarectally infected 
BLT (fi lled circles) or mock-infected control BLT mice (triangles) was ana-
lyzed for RNA viral load (copies per ml plasma, open symbols) and virus 
antigenemia (pg of p24 per ml plasma, fi lled symbols). (C) Western blot 
analysis of plasma from infected mice for the presence of human IgG 
antibodies specifi c for HIV proteins. Lane 1, plasma from a control mouse; 
lanes 2–4, plasma samples from three HIV-infected mice; lane 5, plasma from 
an HIV-infected individual. The position of the different HIV proteins in the 
gel is indicated on the right. (D) Specifi c depletion of human CD4+ cells 
from the peripheral blood of HIV-infected (squares) or control (triangles) 
humanized BLT mice. (E) Human T cell fl ow cytometry profi le of the 
peripheral blood from a representative infected humanized BLT mouse 
2 and 8 wk after intrarectal inoculation with cell-free HIV showing the 
 depletion of CD4+ human T cells.
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out of seven HIV-inoculated BLT mice (Fig. 2 B). Furthermore, 
human IgG anti-HIV–specifi c antibodies were found in the 
plasma of three out of four infected BLT mice tested (Fig. 2 C).
The appearance of viral RNA in the plasma of infected 
BLT mice (Fig. 2 B) preceded or coincided with a decline 
in peripheral blood human CD4+ T cells (Fig. 2 D). This 
decline eventually resulted in an almost complete deple-
tion of human CD4+ T cells from peripheral blood (Fig. 2, 
D and E). Parallel to the decline of CD4+ T cells, there was 
an increase in the percentage of human CD8+ T cells that 
by 8 wk after inoculation represented the vast majority of 
the human T cells in the periphery of infected humanized 
BLT mice (Fig. 2 D). These results demonstrate the striking 
susceptibility of BLT mice to infection by HIV adminis-
tered intrarectally.
Peripheral blood serves as the most accessible site to moni-
tor HIV replication, but the lymphatic tissues are the prin cipal 
sites of virus production, persistence, CD4+ T cell depletion, 
and pathology. We therefore harvested the diff erent internal 
organs from infected mice 8 wk after inoculation and investi-
gated the disseminated systemic infection of lymphatic tissues 
after intrarectal challenge. We found productively infected 
(HIV RNA+) cells in LNs, spleen, and human thymic tissue 
(Fig. 3 A). In addition, we also documented the presence of 
productively infected cells in lung, large and small intestine, 
and the male and female reproductive tracts (Fig. 3 A). Consis-
tent with what has been reported in humans and SIV-infected 
rhesus macaques, we found that most productively infected 
HIV RNA+ cells in humanized BLT mice were in fact human 
T cells (Fig. 3 B). Furthermore, replication-competent HIV 
Figure 3. Disseminated HIV infection of humanized BLT mice. 
(A) In situ hybridization analysis of different tissues from infected humanized 
BLT mice for the presence of cells productively infected with HIV. Auto-
radiograph images were obtained using brightfi eld microscopy. Boxes indi-
cate areas shown at higher magnifi cation on the right where bars indicate 
25 μm and 12.5 μm, respectively. (B) In situ hybridization of HIV-infected 
cells and immunocytochemical analysis for human CD3 expression in 
spleen and lung of humanized BLT mice. Arrows indicate productively 
infected CD3+ human T cells. Bars, 12.5 μm. Productive infection with 
replication competent virus was confi rmed by rescue of infectious virus 
from spleen, human thymic tissue, and bone marrow of infected human-
ized BLT mice by coculture with activated human PBMCs (Fig. S2).
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was recovered from cells isolated from tissues obtained from 
infected mice (Fig. S2, available at http://www.jem.org/cgi/ 
content /full/jem.20062411/DC1). These results highlight the 
disseminated infection that results after intrarectal exposure 
and the striking parallels between BLT mouse and human 
HIV infection in the most relevant tissue compartments.
Systemic depletion of human CD4+ T cells 
in HIV-1–infected BLT mice
We documented a dramatic depletion of human CD4+ T cells 
in bone marrow, human thymic tissue, spleen, and LNs of 
infected BLT mice (Fig. 4 A–C). In addition, there was 
 extensive depletion of human CD4+ T cells from lung and 
liver (Fig. 4, A and C). Furthermore, compared with un-
infected BLT mice, there was a dramatic reduction in the levels 
of human CD4+ T cells in the large and small intestine and 
in the mesenteric LN of HIV-infected mice (Fig. 4 B). His-
tological examination of the human thymic tissue and mouse 
GI tract of infected animals revealed striking pathology (Fig. 
4 D and Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20062411/DC1), most likely caused by loss of thymo-
cytes and stromal collapse. The histological images show the 
dramatic hypocellularity within the large and small intestine 
that is consistent with our fl ow cytometry analysis showing 
a dramatic loss of CD4+ T cells within this compartment 
(Fig. 4 B) (3, 12).
Because depletion of CD4+ T cells from the GALT is a 
major consequence of HIV infection, we characterized the 
human lymphoid cells present in both small and large intes-
tine after infection. Compared with uninfected BLT mice, 
there was a dramatic reduction in the levels of human CD4+ 
T cells in the large and small intestine and in the mesenteric 
LN of HIV-infected mice (Fig. 4 B). Decrease in CD4+ 
T cells coincided with reciprocal increases in the percent-
age of CD8+ T cells. Surprisingly, very few human CD8+ T 
cells were found in the small intestine LPL and IEL fractions 
of HIV-infected mice (Fig. 4, B and C). The proportion of 
CD8+ T cells expressing CXCR4 in mesenteric LN and 
large intestine signifi cantly decreased, whereas the levels of 
CD8+CCR5+ human T cells increased after HIV infection 
compared with uninfected BLT mice (Fig. 5 A). Importantly, 
the most dramatic change in coreceptor expression was noted 
in the mesenteric LNs, which contained very high levels of 
HIV-infected cells (Fig. 3 A) and where virtually all CD8+ 
human T cells expressed high levels of CCR5 (Fig. 5 A). 
Consistent with what is seen in human infections (3), the 
 human T cells remaining in the BLT mouse GI tract after 
 infection (mostly CD8+; Fig. 4 B) had an eff ector memory 
phenotype (CD27− CD45RA−) (Fig. 5 B) (13). Finally, we 
characterized the frequency of CD8+ cells present in the 
lymph node before and after HIV infection for further evi-
dence of a general eff ector T cell response. Consistent with 
their role as a major site of ongoing viral replication and a 
principle immune inductive site, we demonstrated a dramatic 
infi ltration of human CD8+, granzyme+, and perforin+ cells 
within the LNs of HIV-infected BLT mice (Fig. 5 C).
Lymphocyte migration into eff ector tissues like the gut is the 
result of a series of poorly understood but highly complex in-
teractions between cell adhesion molecules, integrins, che-
mokines, and chemokine receptors. Our results demonstrate 
the high degree of compatibility between the mouse and hu-
man systems that results in the appropriate repopulation of 
the mouse gut tissue with human lymphoid cells. For the 
most part, the reconstituted BLT gut clearly resembles hu-
man gut descriptions in the literature (5, 6).  Perhaps the most 
telling features were the presence of human CD4CD8αα 
cells, a T cell subset known only to exist in GALT, and the 
presence of abundant Peyer’s patches in the small intestine 
and lymphoid follicular aggregates in the large intestine local-
ized with human lymphocytes (T and B), macrophages, and 
DCs. In addition, human lymphocytes (T and B), macro-
phages, and DCs were found distributed throughout the ef-
fector lamina propria in humanized BLT mice suggesting that 
these mice have largely “normal human” GALT. However, 
some diff erences were also noted. For example, there was 
heterogeneity in the repopulation of human cells within the 
lamina propria of each humanized BLT mice, with some 
portions of the gut demonstrating lower repopulation. In ad-
dition, there were somewhat higher percentages of CD4+ 
T cells in BLT small intestine IELs compared with normal 
human gut, and no γδT cells were identifi ed. Despite these 
diff erences and based on the remarkable similarities observed 
between the GALT of BLT mice and humans, we tested the 
susceptibility of humanized BLT mice to mucosal HIV trans-
mission. A clear understanding of the molecular basis of mu-
cosal HIV transmission has been hindered to a signifi cant 
extent by the lack of adequate systems that recapitulate the 
events taking place during human infection. Our results show 
remarkable similarities between intrarectally HIV-infected 
humanized mice, HIV-infected humans, and SIV-infected 
macaques including the devastating eff ects to the GALT. 
One notable diff erence was a delay in peak viremia compared 
with infected macaques. The 2-wk delay in peak of vire-
mia is probably because of the chimeric nature of the model, 
with a lower density of viral targets in humanized BLT mice 
compared with macaques, which also could explain the rela-
tively lower magnitude of viremia compared with infected 
macaques. Therefore, from the context of HIV transmissibil-
ity, our observations represent a remarkable fi nding. The fact 
that either very low levels of viral replication takes place in 
regions of low target cell densities or the preservation of virus 
infectivity until localized into tissues with suitable numbers of 
target cells implies that this virus has incredible resilience that 
has not been fully appreciated before.
Because of the limited species tropism of HIV, there are 
few models where potential clinical interventions can be eval-
uated and where pathogenesis can be studied. Mice represent 
an outstanding model to study a variety of aspects related to 
numerous virus infections. However, mice are refractory to 
HIV infection and cannot support HIV replication (14–16). 
Thus, the susceptibility of humanized BLT mice to one intra-
rectal HIV exposure points to the great potential of this  system 
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Figure 4. Depletion of human CD4+ T cells from the GALT of HIV-
infected humanized BLT mice. (A) Flow cytometry analysis of human 
T cells isolated from the indicated organs from a control and an HIV-
 infected humanized BLT mouse. Tissue samples were collected 8 wk after 
inoculation, and mononuclear cells were obtained for fl ow cytometry 
analysis as indicated in Materials and methods. The gating strategy was 
human CD45+®CD3+ and then CD4 and CD8. (B) Depletion of human 
CD4+ T cells from the small and large intestine and mesenteric LN of an 
HIV-infected BLT mouse. (C) Comparison of the percentages of human 
CD4+ T cells between control and HIV-infected BLT mice. Bars represent 
averages of the indicated number of mice (±SEM). Asterisks in C serve to 
indicate the virtual absence of human cells in the small intestine after HIV 
infection. (D) Comparison of thymic and gut tissues of control and HIV-
infected BLT mice showing the considerable damage infl icted by the viral 
infection. Boxes indicate areas of the image shown at higher magnifi cation 
on the right where bars indicate 50 μm and 25 μm, respectively. Larger 
images showing greater detail for thymic organoid and large intestine are 
included in Fig. S3. DP, double positive.
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Figure 5. Phenotypic analysis of human CD8+ T cells before 
and after HIV infection. (A) Coreceptor expression in human CD8+ 
T cells after HIV infection. Cells were isolated from gut tissue 8 wk after 
infection and from a noninfected control BLT mouse. Cells were then 
analyzed for CXCR4 and CCR5 expression. The gating strategy was 
CD45+CD3+CD8+ and then CXCR4 or CCR5. (B) Analysis of CD27 and 
CD45RA expression in human CD8+ T cells from an infected humanized 
BLT mouse. The gating strategy was the same as in A but instead of 
 coreceptor expression, CD27 and CD45RA expression were analyzed. 
(C) Analysis of the effector T cell response to HIV in LNs. Shown are 
 images of lymph node tissue from a control (not infected) BLT mouse and 
an HIV-infected BLT mouse stained for CD8, granzyme B, perforin, and 
HIVp24. Note the dramatic infi ltration by human CD8+ cells and the 
 increase in the numbers of cells expressing granzyme B and perforin 
in the tissue from the infected animal. Bars, 25 μm.
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to study mucosal HIV transmission and prevention. In addi-
tion, the CD4+ T cell depletion and disease-defi ning pathol-
ogy observed in our system demonstrate the utility of this 
small animal model to address key questions regarding HIV-
induced pathogenesis. Furthermore, the AIDS-like pathology 
and depletion of the BLT GALT after HIV infection high-
lights its usefulness to evaluate therapeutic interventions aimed 
at GALT reconstitution that might result in the possible re-
establishment of a functional immune system in humans. 
Therefore, the BLT humanized mouse model has great po-
tential to evaluate novel approaches for the prevention and 
treatment of HIV infection, from preclinical evaluation of 
microbicides to preexposure prophylactic regimens aimed at 
preventing the spread of AIDS.
MATERIALS AND METHODS
Preparation of humanized BLT mice and isolation of tissue 
 lymphocytes for fl ow cytometry analysis. Humanized mice were pre-
pared essentially as we have previously described (4) and maintained under 
specifi c pathogen-free conditions at the University of Texas Southwestern 
Medical Center, at Dallas under protocols approved by the Animal Research 
Committee. In brief, NOD/SCID-hu mice (17) were transplanted with auto-
logous human fetal liver CD34+ cells 3 wk after implantation and monitored 
for human reconstitution in peripheral blood by fl ow cytometry every 2–4 wk 
starting 6 wk after transplant as we have previously described (4). Peripheral 
blood analysis by fl owcytometry was performed using anti–human CD45 
pan-leukocyte antibodies to identify human hematopoietic cells. Using this 
gate, all other human lineages and subsets were analyzed. Animals were anes-
thetized with sodium pentobarbital and then killed via cardiac puncture and 
exsanguinations 24 wk after transplant. Tissues for immunohistochemical 
analysis and for in situ hybridization analysis were fi xed immediately upon 
harvest and shipped to Dr. A.T. Haase in Minnesota for processing and analy-
sis within 48 h of harvest. Immunohistochemical stainings and in situ hybrid-
ization analysis were performed essentially as previously described (4, 12, 18). 
For controls, tissues were stained with isotype match nonspecifi c antibodies. 
The specifi city of each stain was also confi rmed by staining tissue from 
NOD/SCID control animals with the same antibodies to human antigens. 
Tissue and blood samples were processed immediately for cell isolation and 
fl ow cytometry analysis. The gating strategy for each subset of cells included 
fi rst human CD45 to identify human cells and to exclude mouse cells from 
the analysis. Human cells were then analyzed for the specifi c human leuko-
cyte antigens indicated in Figs. 1, 2, 4, 5, and S1. Flow cytometry data were 
collected on the same day of harvest using a FACSCanto instrument with 
Diva software. Isolation of cells from the gut took 5 h. In brief, single cell 
suspensions for analysis were prepared essentially as we have previously de-
scribed (4) except for GALT. GALT cells were prepared as previously de-
scribed (19, 20) with modifi cations. Small and large intestine were fl ushed 
with ice cold PBS, cut into 1-inch segments, and inverted to expose the 
intraepithelial surface. These segments were washed fi ve times by vigor-
ous shaking in cold PBS, allowed to settle by gravity, then resuspended in 
15–25 ml IEL extraction medium (freshly made; 3% FBS, 1 mM DTT, 1 mM 
EDTA in PBS). These mixtures were shaken gently for 30 min on a rotating 
platform at 37°C, then vigorously for 2 min at RT. The IEL supernatants 
were collected through a 70-μm cell strainer (Falcon). The intestinal seg-
ments were thoroughly washed and incubated for 60 min on a rotating plat-
form at 37°C in 15–25 ml LPL digestion medium (freshly made; 60 μg/ml 
collagenase D and 10 U/ml DNaseI in RPMI-1640). During this incubation, 
the IEL supernatants were passed over IEL extraction medium–equilibrated 
columns of 0.5 g of dimethyldichlorosilane-treated glass wool fi ber (Fisher) in 
10-ml syringes. The column fl ow-through fractions were washed at 200 g for 
5 min at 4°C, resuspended in solution B (0.5% BSA, 1 μg/ml penicillin G, 
1 U/ml streptomycin, 1% citrate phosphate dextrose solution [CPD; Baxter], 
25 mM KH2PO4, and 25 mM K2HPO4), and placed on ice. After the LPL 
digestion, the suspensions were shaken mildly for 1 min at RT. The LPL super-
natants were collected through a 70-μm cell strainer, washed at 200 g for 
5 min at 4°C, resuspended in solution B, and placed on ice. Live cells from 
both the IEL and LPL fractions of the small and large intestines were then 
counted using trypan blue exclusion and used for fl ow cytometry analysis.
Intrarectal infection of humanized mice with HIV. Virus stocks were 
prepared and titrated and p24 content was determined as we have previously 
described (21, 22). Before inoculation, mice were anesthetized with sodium 
nembutal. Intrarectal inoculations were performed essentially as previously 
described using a total volume of 60–80 μL of virus (200 ng p24, 9 × 104 
TCIU) (23).
Analysis of HIV infection of humanized mice. Infection of BLT mice 
with HIV was monitored in peripheral blood every 2 wk by determining 
 viral load (Amplicore; Roche), levels of viral antigenemia (ELISA p24; Beckman 
Coulter), and the levels of human CD4+ and CD8+ T cells in peripheral 
blood (fl ow cytometry), and by determining the presence of human anti-
bodies to HIV proteins in plasma essentially as we have previously described 
(4, 21). Analysis of systemic infection was performed 8 wk after infection by 
in situ hybridization, immunohistochemistry, and fl ow cytometry also as we 
have previously described (4, 12). Rescue of infectious virus from diff erent 
tissues was performed by coculture with PHA-activated PBMC from HIV 
seronegative donors, and viral spread was monitored by determining p24 
levels in the culture supernatant. Human CD4+ T cell depletion was moni-
tored in all tissues indicated essentially as we have previously described ex-
cept that the six-color fl ow cytometry analysis also included determination 
of CCR5 and CXCR4 expression (4).
Online supplemental material. Fig. S1 shows immunohistochemical 
analysis for human CD11c and HLA-DR–positive cells in the gut of BLT 
mice and fl ow cytometry analysis for the presence of human DC and NK 
cells. In addition, it demonstrates the lack of cross-reactivity of the human-
specifi c antibodies used with mouse antigens. Fig. S2 demonstrates the res-
cue of replication-competent HIV from the spleen, thymic organoid, and 
bone marrow of infected BLT mice. Fig. S3 presents high resolution images 
showing the histopathological changes observed in the thymic organoid and 
large intestine during HIV infection. Figs. S1–S3 available at http://www
.jem.org/cgi/ content /full/jem.20062411/DC1.
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